We're excited to be part of the Asia-Pacific Heart Rhythm Society (APHRS) Congress, the premier EP conference in the APAC region, happening from September 26-29. APHRS unites over 3,000 cardiologists and electrophysiologists to discuss the latest in evidence-based medicine and cutting-edge arrhythmia research.​
​
Explore the future of Afib treatment with Hybrid AF™ Therapy —a novel strategy combining the benefits of both catheter ablation and surgical techniques to deliver improved outcomes. Connect with industry leaders and discover how Hybrid AF Therapy is advancing the treatment of long-standing persistent Afib at <a href='https://www.linkedin.com/feed/hashtag/?keywords=APHRS2024.&highlightedU…; target='_blank'>#APHRS2024.</a>​
​
We hope to see you there!